Bio
Dr. Wen-Kai Weng specializes in the treatment of non-Hodgkin's lymphoma (NHL), his basic research interest is immunotherapy for lymphoma and cancer, with two components: tumor specific targeting therapy and allogeneic transplant. He is currently working on new strategies to target patient-specific tumor using antibody along with effector cells. He is also conducting clinical study looking at the clinical efficacy of allogeneic transplant in patients with cutaneous lymphoma.
Clinical Focus
- Cancer > Blood and Marrow Transplant
- Cancer > Lymphoma
- Cutaneous T-Cell Lymphoma
- Medical Oncology
- Chimeric Antigen Receptor (CAR) T-cell Therapy
- Immunotherapy
Academic Appointments
-
Associate Professor - Med Center Line, Medicine - Blood & Marrow Transplantation
-
Associate Professor - Med Center Line (By courtesy), Dermatology
-
Member, Stanford Cancer Institute
Administrative Appointments
-
Scientific Advisory Board, Lymphoma Research Foundation (2011 - 2012)
-
Co-Director, Stanford Multidisciplinary Cutaneous Lymphoma Clinic (2014 - Present)
-
Director, Blood and Marrow Transplantation/Cellular Therapy (BMT/CT) Fellowship Program (2015 - Present)
Honors & Awards
-
Predoctoral National Research Service Award, NIH/NIAID (1994-1995)
-
Doctoral Dissertation Award, University of Minnesota Graduate School (1995)
-
Charles and Dorothy Andrew Bird Award, Sigma Xi Scientific Research Society (1996)
-
Fellowship, Lymphoma Research Foundation (2002-2004)
-
K08 Clinical Scientist Career Development Award, NIH/NCI (2005-2009)
-
Developmental Research Award, Stanford University Cancer Center (2009-2010)
-
ITI Seed Grant Award, Institute for Immunity, Transplantation and Infection, Stanford University (2011-2012)
-
Developmental Research Award, Stanford Cancer Institute (2012-2013)
-
Translational Research Grant, Stanford Cancer Institute (2014-2015)
-
Division Teaching Award, BMT, Stanford University (2009, 2010, 2012, 2015, 2016, 2018, 2019)
Boards, Advisory Committees, Professional Organizations
-
Co-Director, Stanford Cancer Immunotherapy and Blood & Marrow Transplantation Symposium (2018 - Present)
Professional Education
-
Fellowship, Stanford University, Medical Oncology (2002)
-
Residency, University of Texas-Houston, Internal Medicine (1999)
-
Internship, University of Texas-Houston, Internal Medicine (1997)
-
PhD, University of Minnesota, Pathobiology/Immunology (1996)
-
MD, ChungShan Medical and Dental College, Medicine (1988)
Patents
-
Ronald Levy, Wen-Kai Weng. "United States Patent 9109255 Methods and compositions for determining responsiveness to antibody therapy", Aug 18, 2015